Enlivex Therapeutics to Invest in Bitcoin as Part of Cash Management Strategy

According to PANews, Enlivex Therapeutics Ltd., a publicly traded company in the United States, has announced its board's approval to purchase up to $1 million in Bitcoin. This decision is part of the company's cash management strategy. Oren Hershkovitz, the CEO of Enlivex, highlighted the growing demand for Bitcoin and its increasing acceptance as a recognized medium of exchange. He expressed... source: https://www.binance.com/en/square/post/16536084248818?utm_source=BinanceNewsRSS